Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ERK Inhibition Promotes Engraftment of Allografts by Reprogramming T-Cell Metabolism. | Adv Sci (Weinh) | 2023 | 37013935 | PubTator, text mining | PubMed |
| Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis. | BMC Cancer | 2023 | 37013511 | PubTator, text mining | PubMed |
| Development and validation of a tumor immune cell infiltration-related gene signature for recurrence prediction by weighted gene co-expression network analysis in prostate cancer. | Front Genet | 2023 | 37007952 | PubTator, text mining | PubMed |
| T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing. | Front Immunol | 2023 | 37006257 | PubTator, text mining | PubMed |
| Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via EZH2/STAT pathway. | Sci Rep | 2023 | 37005451 | PubTator, text mining | PubMed |
| Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade. | Cancer Cell | 2023 | 37001526 | PubTator, text mining | PubMed |
| Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies. | Thromb Res | 2023 | 37001283 | PubTator, text mining | PubMed |
| Cancer immunity and immunotherapy beyond COVID-19. | Cancer Immunol Immunother | 2023 | 36995489 | PubTator, text mining | PubMed |
| Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID. | Vaccines (Basel) | 2023 | 36992283 | PubTator, text mining | PubMed |
| Smart Polymeric Nanoparticles in Cancer Immunotherapy. | Pharmaceutics | 2023 | 36986636 | PubTator, text mining | PubMed |
| Molecular Markers of Blood Cell Populations Can Help Estimate Aging of the Immune System. | Int J Mol Sci | 2023 | 36982782 | PubTator, text mining | PubMed |
| The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. | Cancers (Basel) | 2023 | 36980527 | PubTator, text mining | PubMed |
| Revealing the Heterogeneity of the Tumor Ecosystem of Cholangiocarcinoma through Single-Cell Transcriptomics. | Cells | 2023 | 36980203 | PubTator, text mining | PubMed |
| Identification of Prognosis-Related Oxidative Stress Model with Immunosuppression in HCC. | Biomedicines | 2023 | 36979675 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review. | Biology (Basel) | 2023 | 36979163 | PubTator, text mining | PubMed |
| TEDC2 correlated with prognosis and immune microenvironment in lung adenocarcinoma. | Sci Rep | 2023 | 36973475 | PubTator, text mining | PubMed |
| Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy. | Cancer Biol Med | 2023 | 36971124 | PubTator, text mining | PubMed |
| The construction and analysis of tricarboxylic acid cycle related prognostic model for cervical cancer. | Front Genet | 2023 | 36968582 | PubTator, text mining | PubMed |
Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome. | Clin Transl Med | 2023 | 36967539 | PubTator, text mining | PubMed |
| Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy. | J Transl Med | 2023 | 36967379 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=31